This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Csl Limited and Csl Innovation Pty Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Walid Azar - Innovator in Hemostasis Therapy
Introduction
Walid Azar is an inventor based in Melbourne, Victoria, Australia. He is currently associated with CSL Innovation Pty Ltd, where he contributes to advancements in medical therapies. Although he has not yet been granted any patents, his work focuses on significant innovations in the field of hemostasis.
Latest Patent Applications
Walid Azar's notable patent application is titled "Factor IX Variants and Uses Thereof in Therapy." This invention provides Factor IX variants, molecules comprising the variants, nucleic acids encoding the variants, compositions comprising the variants or the nucleic acids encoding the variants, and their use in methods for the modulation of hemostasis, for example in the prophylaxis or treatment of hemophilia B. The Factor IX variants have improved biological properties relative to other Factor IX variants and/or relative to wild-type Factor IX.
Conclusion
Walid Azar is making strides in the field of hemostasis therapy through his innovative research and patent applications. His contributions have the potential to significantly impact the treatment of hemophilia B.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile